PE20001061A1 - Particulas aerosolizables resistentes al crecimiento higroscopico - Google Patents
Particulas aerosolizables resistentes al crecimiento higroscopicoInfo
- Publication number
- PE20001061A1 PE20001061A1 PE1999000925A PE00092599A PE20001061A1 PE 20001061 A1 PE20001061 A1 PE 20001061A1 PE 1999000925 A PE1999000925 A PE 1999000925A PE 00092599 A PE00092599 A PE 00092599A PE 20001061 A1 PE20001061 A1 PE 20001061A1
- Authority
- PE
- Peru
- Prior art keywords
- active agent
- hygroscopic
- particles
- hygroscopic growth
- refers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
SE REFIERE A PARTICULAS QUE CONTIENEN a)UN AGENTE ACTIVO; b)UN INHIBIDOR DE CRECIMIENTO HIGROSCOPICO TAL COMO FOSFOLIPIDOS DE CADENA DOBLE, CICLODEXTRINAS, HIDROETILALMIDON, DEXTRANO, DEXTRANOMERO, MALTODEXTRANO, HIDROXIPROPILCELULOSA, HIDROXIPROPILMETILCELULOSA, ETER HIDROXIETILICO DE ETILCELULOSA EN CANTIDAD SUFICIENTE PARA QUE LA PARTICULA EXHIBA UNA TASA DE ABSORCION DE HUMEDAD DE NO MAS DE 0,5% EN FUNCION DE LA HUMEDAD RELATIVA; O UN NIVEL DE ABSORCION DE AGUA DE NO MAS DE 30% EN PESO A UNA HUMEDAD RELATIVA DE 80%; LAS PARTICULAS SE CARACTERIZAN i)POR EXHIBIR UNA CAIDA DE LA DOSIS EMITIDA DE NO MAS DE 25% EN CONDICIONES SIMULADAS O EN CONDICIONES AMBIENTE DE POR LO MENOS 60%; ii)TIENEN UN INDICE DE SORCION INFERIOR A 6,5%; iii)TAMANO DE PARTICULAS ES INFERIOR A 3 MICRONES. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION QUE COMPRENDE PREPARAR UNA MEZCLA DE UN INHIBIDOR DEL CRECIMIENTO HIGROSCOPICO, UN AGENTE ACTIVO Y UN SOLVENTE (AGUA); SECAR POR ROCIO LA MEZCLA PARA OBTENER PARTICULAS HOMOGENEAS DEL AGENTE HIGROSCOPICO Y EL AGENTE ACTIVO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10016398P | 1998-09-14 | 1998-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001061A1 true PE20001061A1 (es) | 2000-10-08 |
Family
ID=22278404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000925A PE20001061A1 (es) | 1998-09-14 | 1999-09-13 | Particulas aerosolizables resistentes al crecimiento higroscopico |
Country Status (44)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| JP4874483B2 (ja) | 1999-06-09 | 2012-02-15 | ロバート イー． シーバース | 超臨界流体補助ネブライゼーション及びバブル乾燥 |
| US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| CA2446904A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| CA2465675C (en) | 2001-11-20 | 2008-06-10 | Advanced Inhalation Research, Inc. | Improved particulate compositions for pulmonary delivery |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| UA83341C2 (uk) | 2002-02-25 | 2008-07-10 | Дифьюжен Фармасьютикалз Ллк | Біополярні солі транс-каротиноїдів та їх використання |
| AU2003232081B2 (en) * | 2002-07-03 | 2009-02-05 | Brandeis University | Central airway administration for systemic delivery of therapeutics |
| CA2511385A1 (en) * | 2002-12-19 | 2004-07-22 | Pharmacia Corporation | Non-hygroscopic formulation comprising a hydroscopic drug |
| DE10338403A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| ES2909080T3 (es) | 2004-04-23 | 2022-05-05 | Cydex Pharmaceuticals Inc | Formulación de DPI que contiene sulfoalquil éter ciclodextrina |
| US8030350B2 (en) | 2005-02-24 | 2011-10-04 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
| BRPI0608844A2 (pt) * | 2005-03-09 | 2010-02-02 | Ono Pharmaceutical Co | partìcula e preparação que contém a partìcula |
| ES2526903T3 (es) | 2005-10-26 | 2015-01-16 | Cydex Pharmaceuticals, Inc. | Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| US20080035143A1 (en) * | 2006-08-14 | 2008-02-14 | Sievers Robert E | Human-powered dry powder inhaler and dry powder inhaler compositions |
| KR20090081407A (ko) * | 2006-10-25 | 2009-07-28 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 고결 방지 과립상 제제 |
| EP1925295A1 (de) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
| MX2009010988A (es) | 2007-04-13 | 2010-03-15 | Diffusion Pharmaceuticals Llc | Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica. |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| MX2010004803A (es) | 2007-10-31 | 2010-09-09 | Diffusion Pharmaceuticals Llc | Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas. |
| US9610343B2 (en) * | 2009-05-20 | 2017-04-04 | Aeras Global Tb Vaccine Foundation | Stable, spray dryed, immunogenic, viral compositions |
| EP2445339B1 (en) | 2009-06-22 | 2019-08-07 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compound and its use with a thrombolytic |
| ES2654945T3 (es) | 2010-06-02 | 2018-02-15 | Diffusion Pharmaceuticals Llc | Formulaciones orales de carotenoides trans bipolares |
| US9682096B2 (en) | 2012-05-02 | 2017-06-20 | Janssen R & D Ireland | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections |
| WO2014074797A1 (en) * | 2012-11-09 | 2014-05-15 | Civitas Therapeutics, Inc. | Ultra low density pulmonary powders |
| WO2015042352A1 (en) * | 2013-09-20 | 2015-03-26 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
| CA2965759C (en) | 2014-10-31 | 2023-12-12 | Glaxosmithkline Intellectual Property Development Limited | Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials |
| WO2017165667A1 (en) | 2016-03-24 | 2017-09-28 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| ATE222754T1 (de) * | 1992-06-12 | 2002-09-15 | Teijin Ltd | Ultrafeines pulver zur inhalation und dessen herstellung |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| WO1998031346A1 (en) * | 1997-01-16 | 1998-07-23 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/fr unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 EE EEP200100151A patent/EE200100151A/xx unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/xx not_active IP Right Cessation
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Ceased
- 1999-09-13 UA UA2001031707A patent/UA76085C2/uk unknown
- 1999-09-13 TW TW088115876A patent/TWI226248B/zh not_active IP Right Cessation
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/ja not_active Withdrawn
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/es unknown
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/xx active
- 1999-09-13 ID IDW20010582A patent/ID28845A/id unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 AR ARP990104587A patent/AR022090A1/es unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/cs unknown
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/es not_active Application Discontinuation
- 1999-09-13 CN CN99810871A patent/CN1317977A/zh active Pending
- 1999-09-13 YU YU24201A patent/YU24201A/sh unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/xx unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/pt not_active IP Right Cessation
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/sk unknown
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/hu unknown
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/ko not_active Ceased
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/hr not_active Application Discontinuation
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/zh unknown
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/ru active IP Right Revival
- 1999-09-13 PL PL99346768A patent/PL195574B1/pl not_active IP Right Cessation
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/es unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/fr unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/es unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/es unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/es not_active Application Discontinuation
- 1999-10-31 SA SA99200718A patent/SA99200718B1/ar unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/is unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/no not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/lt not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/xx unknown
- 2001-04-10 BG BG105430A patent/BG105430A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20001061A1 (es) | Particulas aerosolizables resistentes al crecimiento higroscopico | |
| AR018891A1 (es) | Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol | |
| BR0314269A (pt) | Cápsulas contendo composições aquosas de recheio estabilizadas com ciclodextrina derivatizada | |
| ES8305411A1 (es) | Un procedimiento para la preparacion de un producto deter- gente desodorante. | |
| CN101297659A (zh) | 一种环丙烯类包结物胶囊及其制备方法 | |
| AR048711A1 (es) | Composicion acuosa fungicida y su uso para combatir microorganismos nocivos | |
| CY1116503T1 (el) | Φαρμακευτικες συνθεσεις για εισπνοη υπο μορφη ξηρης σκονης, διαλυματων ή εναιωρηματων | |
| AR068612A1 (es) | Microemulsiones acuosas que contienen compuestos insecticidas organicos | |
| ES2101330T3 (es) | Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado. | |
| BR112015015136B1 (pt) | Composição de pasta dental, método de promoção de higiene oral e uso não terapêutico de uma composição de pasta dental | |
| DE60116758D1 (de) | Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform | |
| BR0015676A (pt) | Composição pesticida, método para controlar pestes, e, uso de uma composição de gel aerado estável em armazenamento | |
| JP2013536874A (ja) | 鼻腔噴霧剤 | |
| BR0110351A (pt) | Composição de gel aerado biocida estável na armazenagem, método de controle de roedores, método de controle de insetos, e, método de preparo de uma composição de gel biocida aerado, particulado, estável em armazenagem | |
| AR058323A1 (es) | Formulacion de suspension de fexofenadina | |
| EA036809B1 (ru) | Антивирусная фармацевтическая композиция | |
| CN105288652A (zh) | 一种超氧化物歧化酶微囊粉及其配制方法 | |
| ES8600930A1 (es) | Un metodo para producir un preparado granular que contiene procimidona, facilmente dispersable en agua | |
| ATE526032T1 (de) | Stabilisierte flüssige interferon-formulierungen | |
| RS58731B1 (sr) | Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa | |
| CN103392730A (zh) | 一种杀扑磷皮克林水乳剂及其制备方法 | |
| AR056062A1 (es) | Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion | |
| WO2016017784A1 (ja) | 含水流動状組成物及びその製造方法、並びに、リゾチーム加工品及び／又はその塩並びにその製造方法 | |
| Bayülgen et al. | Effect of oleanolic acid for prevention of acute lung injury and apoptosis | |
| KR20210103641A (ko) | 수용성 삼종염 살균소독제 복합조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |